Table 2.
Groups versus control# | LVEF | MACE | ||||||
---|---|---|---|---|---|---|---|---|
Number of studies | Number of patients | I 2 | MD (95% CI) | Number of studies | Number of patients | I 2 | OR (95% CI) | |
6 months | ||||||||
1~7 days | 23∗ | 862/673 | 71.8 | 2.57 (1.21~3.94) | 16 | 768/571 | 0.0 | 0.51 (0.31~0.82) |
1~3 days | 6 | 142/127 | 36.2 | 1.26 (−0.66~3.18) | 4 | 143/104 | 0.0 | 1.03 (0.30~3.47) |
4~7 days | 18 | 881/674 | 72.3 | 2.85 (1.61~4.09) | 12 | 625/467 | 0.0 | 0.44 (0.26~0.76) |
8~14 days | 3 | 34/30 | 0.0 | −0.84 (−4.31~2.64) | 0 | 0 | — | — |
15~30 days | 5 | 187/169 | 87.1 | 3.27 (−1.94~8.48) | 4 | 167/140 | 0.0 | 1.79 (0.66~4.82) |
Total | 30 | 1083/872 | 73.6 | 2.53 (1.25~3.82) | 19$ | 935/711 | 0.0 | 0.66 (0.43~1.01) |
12 months | ||||||||
1~7 days | 10 | 311/240 | 50.0 | 4.34 (2.98~5.69) | 9 | 342/296 | 12.7 | 0.31 (0.18~0.55) |
1~3 days | — | — | — | — | — | — | — | — |
4~7 days | 10 | 311/240 | 50.0 | 4.34 (2.98~5.69) | 9 | 342/296 | 12.7 | 0.31 (0.18~0.55) |
8~14 days | 2 | 10/10 | 0.0 | 2.33 (−3.95~8.62) | 4 | 42/35 | 0.0 | 0.65 (0.15~2.84) |
15~30 days | 1 | 19/20 | — | 1.30 (−3.09~5.69) | 1 | 21/21 | — | 2.11 (0.18~25.17) |
Total | 13 | 340/270 | 42.6 | 4.09 (2.83~5.34) | 14 | 405/352 | 0.0 | 0.45 (0.27~0.76) |
∗One study had arms belonging to 1~3 days' group and another one belonging to 8~14 days' group; $one study had arms belonging to 8~14 days' group and another one belonging to 15~30 days' group. #Multiarm studies were divided into independent studies.